日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

chinadaily.com.cn
left corner left corner
China Daily Website

Medical reforms spell out profit for pharma giants

Updated: 2013-04-13 14:37
By Liu Jie ( China Daily)

China now has 148 million people with pre-diabetes on top of an existing 92.4 million diabetes patients.

The number of patients is forecast to reach 130 million by 2030, creating medical costs related to type-2 diabetes of $47.2 billion, according to International Diabetes Federation.

In the China National Plan for Chronic Diseases Prevention and Treatment (2012-2015), diabetes has been given specific importance.

"Our advantage is in early-stage diabetes treatment. Our Glucophage (an oral diabetes medicine that helps control blood sugar levels) is recommended as initial treatment within national guidelines," said Jean-Christophe Pointeau, president of Bristol-Myers China.

The medicine is on China's essential drug list and Pointeau said he expects another Bristol-Myers product - Onglyza, a prescription type 2 diabetes medicine - also to be included.

Another major international name, Boston Scientific Co, has just announced clinical results of a trial evaluating the safety and effectiveness of a cardiovascular stent system in China.

Clinical trials are the prerequisite of new product introduction.

The US company is also working to introduce more specialist treatment to the Chinese market, including those involved in cardiology and endoscopy, especially in the treatment of chronic conditions, said Michael F. Mahoney, Boston Scientific's CEO.

Since entering China in 1997, the company's average annual growth by sales has kept at 30 percent and it expects to exceed that figure in coming years.

The company is also building a research and development, training and head office complex in Shanghai, which is expected to be completed in September.

China expects to increase its medical spending by 27 percent this year, and to more than double the number of drugs in its national reimbursement medicine list from 205 to 520.

China's medical insurance will cover an additional 20 serious illnesses, including lung and gastric cancers, chronic myelocytic leukemia, hemophilia, type-1 diabetes and cerebral infarction.

These are also other serious diseases seeing increased occurrence in China, which lack high-quality diagnosis and treatment equipment being produced by domestic companies, according to a recent report from Bank of China International (China) Ltd.

Sanofi's Lam added that so far the company cannot assess how successful its investment in the Chinese market has been, "but we believe in the long run, it will be absolutely positive to us".

Sanofi's diabetes business increased 25 percent year-on-year in 2012, compared with the average growth of the sector at 15 percent.

 
 
...
主站蜘蛛池模板: 狠狠五月 | 日本在线精品视频 | 久久久久1 | 欧美黄色免费在线观看 | 日韩tv | av一二| 九九在线| 亚洲图片另类 | 麻豆国产在线 | 久久免费在线观看视频 | 久久久久黄 | 伊人色婷婷| 日爽夜爽 | 欧美久久久久久久久久 | 免费观看黄色一级视频 | 国产88在线观看入口 | 午夜精品福利在线观看 | 欧美一区二区三区四区五区 | 性欧美日本| 中文有码在线播放 | 亚洲黄色在线看 | 成人av影视 | 操女人的软件 | 一区二区三区在线观看视频 | 97国产视频| 国产成人精品一区二区三区视频 | 99爱视频| 91偷拍精品一区二区三区 | 色网站在线播放 | 久久久久久久免费视频 | 四虎永久在线观看 | 深夜福利视频在线观看 | 密桃成人av | 国产片一区二区 | 亚洲男人天堂 | 在线观看国产精品一区 | 伊人久久精品一区二区三区 | 国产精品suv一区二区69 | 成人在线免费看 | 日韩在线观看一区二区 | 91久久综合亚洲鲁鲁五月天 |